Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
Cefepime Kabi
Cefepime dihydrochloride monohydrate 1.1892g equivalent to cefepime 1g
Powder for injection
Fresenius Kabi New Zealand Limited
Fresenius Kabi iPSUM S.r.l, Rovigo, Italy
Labesfal Laboratories Almiro SA, Santiago de Besteiros, Portugal
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
Cefepime Kabi
Cefepime dihydrochloride monohydrate 2.3785g equivalent to cefepime 2g
Powder for injection
Fresenius Kabi New Zealand Limited
Fresenius Kabi iPSUM S.r.l, Rovigo, Italy
Labesfal Laboratories Almiro SA, Santiago de Besteiros, Portugal
|
|
Product:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Hydralyte Strawberry Kiwi Flavoured Electrolyte Ice Blocks
Citric acid monohydrate 4.8mg/mL
Glucose monohydrate 16mg/mL
Potassium citrate monohydrate 2.213mg/mL
Sodium chloride 2.528mg/mL
Oral solution
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Tismor Health and Wellness Pty Limited, Sydney, Australia
|
Dated this 1st day of February 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz